Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2026
AI-driven PROTAC design overcomes oncogenic resilience by eliminating the CLIP1-LTK fusion proteinShicheng Chen, Haiting Duan, Sheng Zhong, et al.
Acta Pharmaceutica Sinica. B|May 4, 2023
AKT inhibitor Hu7691 induces differentiation of neuroblastoma cellsShaowei Bing, Senfeng Xiang, Zhimei Xia, et al.
European Journal of Medicinal Chemistry|June 14, 2024
Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic strokeYang Lu, Haoran Lin, Yaping Xu, et al.
Journal of Medicinal Chemistry|March 12, 2019
Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple SclerosisQinjie Weng, Jinxin Che, Zhikang Zhang, et al.
European Journal of Medicinal Chemistry|September 6, 2021
Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitorsChenghao Pan, Wenwen Nie, Jiao Wang, et al.
The American Journal of Gastroenterology|July 10, 2026
Association of Intrapancreatic Fat Deposition with Mortality: A Prospective Cohort Study with Genetic Risk ProfilingXiaowu Dong, Qingtian Zhu, Zhiyin Huang, et al.
European Journal of Medicinal Chemistry|March 11, 2023
A practical "preTACs-cytoblot" platform accelerates the streamlined development of PROTAC-based protein degradersZijian Rao, Kailin Li, Ju Hong, et al.
International Immunopharmacology|June 26, 2023
AKBA alleviates experimental pancreatitis by inhibiting oxidative stress in Macrophages through the Nrf2/HO-1 pathwayChenchen Yuan, Xiaowu Dong, Songxin Xu, et al.
European Journal of Medicinal Chemistry|April 3, 2022
Design, synthesis and biological evaluation of sulfonamides inhibitors of XPO1 displaying activity against multiple myeloma cellsBingxue Qu, Yongjin Xu, Yang Lu, et al.
Frontiers in Pharmacology|October 24, 2025
Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experimentsXin Gao, Zouhua Xu, Qingxie Liu, et al.
Pageof 19